Literature DB >> 12505293

Developing a pharmacovigilance system in the Philippines, a country of diverse culture and strong traditional medicine background.

Kenneth Hartigan-Go1.   

Abstract

Pharmacovigilance is the study of adverse drug reactions (ADR, events-AE). It affords a unique vantage point from which to detect problem drugs and drug use. The ADR reporting system in the Philippines was established in August 1994 and was recognized as a national centre member of the World Health Organization International Drug Monitoring (currently known as the Uppsala Monitoring Centre) by February 1995. The pharmacovigilance system in the Philippines developed a number of communication and training packages with the intention of advocating safer medicines and rational drug use. Although unpopular with western-trained medical doctors, people do utilize traditional folk medicines. There have been few ADR reports, perhaps in part because the AE are unrecognized; sometimes, the AE is misconstrued as part of the healing action; and practitioners of these remedies are unlikely to report them. People who resort to herbal medicines are usually from the poor segment of the population, and are likely to believe in unscientific claims and unlikely to report what they suffered. The promotion of herbal medicines as natural safe alternatives neglects the possibility of AE. Although unregulated, traditional Chinese medicines are allowed in the Philippines if used by ethnic Chinese. The regulation of health supplements has also been inefficient. Both of these factors have provided gaps for the entry of harmful products. Pharmacovigilance programmes are useful in the detection of false claims and substandard medicines. Examples of the Philippine ADR monitoring experience are cited.

Entities:  

Mesh:

Year:  2002        PMID: 12505293     DOI: 10.1016/s0300-483x(02)00263-9

Source DB:  PubMed          Journal:  Toxicology        ISSN: 0300-483X            Impact factor:   4.221


  6 in total

1.  Safety culture in a pharmacy setting using a pharmacy survey on patient safety culture: a cross-sectional study in China.

Authors:  P L Jia; L H Zhang; M M Zhang; L L Zhang; C Zhang; S F Qin; X L Li; K X Liu
Journal:  BMJ Open       Date:  2014-06-30       Impact factor: 2.692

2.  Perceptions, practices and barriers to reporting of adverse drug reactions among HIV infected patients and their doctors in 3 public sector hospitals of the Ethekwini Metropolitan, Kwa-Zulu Natal: a cross sectional and retrospective analysis.

Authors:  Sindiswa Zondi; Panjasaram Naidoo
Journal:  BMC Health Serv Res       Date:  2022-08-18       Impact factor: 2.908

3.  Adverse drug reactions reporting : Knowledge and opinion of general public in Penang, Malaysia.

Authors:  Ramadan Elkalmi; Mohamed Azmi Hassali; Omar Qutaiba Al-Lela; Ammar Ihsan Jawad Awadh; Abdul Kareem Al-Shami; Shazia Qasim Jamshed
Journal:  J Pharm Bioallied Sci       Date:  2013-07

Review 4.  Pharmacovigilance in Asia.

Authors:  Pipasha Biswas
Journal:  J Pharmacol Pharmacother       Date:  2013-12

5.  Texting-Based Reporting of Adverse Drug Reactions to Ensure Patient Safety: A Feasibility Study.

Authors:  Godofreda Vergeire-Dalmacion; Nina T Castillo-Carandang; Noel R Juban; Maria Lourdes Amarillo; Maria Pamela Tagle; Emmanuel S Baja
Journal:  JMIR Public Health Surveill       Date:  2015-11-19

Review 6.  Strategies and Systems-Level Interventions to Combat or Prevent Drug Counterfeiting: A Systematic Review of Evidence Beyond Effectiveness.

Authors:  Racha Fadlallah; Fadi El-Jardali; Farah Annan; Hayat Azzam; Elie A Akl
Journal:  Pharmaceut Med       Date:  2016-08-19
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.